"10.1371_journal.pone.0125522","plos one","2015-04-24T00:00:00Z","Ka-Man Venus Lai; Guochun Gong; Amanda Atanasio; Jos√© Rojas; Joseph Quispe; Julita Posca; Derek White; Mei Huang; Daria Fedorova; Craig Grant; Lawrence Miloscio; Gustavo Droguett; William T Poueymirou; Wojtek Auerbach; George D Yancopoulos; David Frendewey; John Rinn; David M Valenzuela","VelociGene, Regeneron Pharmaceuticals, Inc., Tarrytown, New York, United States of America; Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, Massachusetts, United States of America; Broad Institute of MIT and Harvard, Cambridge, Massachusetts, United States of America","Conceived and designed the experiments: K-MVL WA D. Frendewey GDY J. Rinn DMV. Performed the experiments: GG AA J. Rojas JQ JP DW MH D. Fedorova CG LM GD WTP. Analyzed the data: K-MVL GG AA J. Rojas JQ JP DW MH D. Fedorova CG LM GD WTP WA D. Frendewey DMV. Wrote the paper: K-MVL GG D. Frendewey DMV.","K-MVL, GG, AA, J. Rojas, JQ, JP, DW, MH, D. Fedorova, CG, LM, GD, WTP, WA, GDY, DF, DMV are employees of VelociGene, Regeneron Pharmaceuticals, Inc. A patent application has been filed relating to this work, title: LincRNA-deficient non-human animals and application No: US 14/454,464 and PCT/US2014/050178. There is no product in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.","2015","04","Ka-Man Venus Lai","KMVL",18,TRUE,3,3,4,3,TRUE,TRUE,TRUE,4,"8;10;11;13",TRUE
